JP2024524502A5 - - Google Patents
Info
- Publication number
- JP2024524502A5 JP2024524502A5 JP2023581075A JP2023581075A JP2024524502A5 JP 2024524502 A5 JP2024524502 A5 JP 2024524502A5 JP 2023581075 A JP2023581075 A JP 2023581075A JP 2023581075 A JP2023581075 A JP 2023581075A JP 2024524502 A5 JP2024524502 A5 JP 2024524502A5
- Authority
- JP
- Japan
- Prior art keywords
- physiologically acceptable
- boulardii
- saccharomyces
- composition according
- marxianus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21382576.3 | 2021-06-30 | ||
| EP21382576 | 2021-06-30 | ||
| EP22382114 | 2022-02-11 | ||
| EP22382114.1 | 2022-02-11 | ||
| PCT/EP2022/068151 WO2023275293A1 (en) | 2021-06-30 | 2022-06-30 | Physiologically acceptable yeast compositions and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024524502A JP2024524502A (ja) | 2024-07-05 |
| JP2024524502A5 true JP2024524502A5 (cg-RX-API-DMAC7.html) | 2025-06-30 |
Family
ID=82308337
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023581073A Pending JP2024524501A (ja) | 2021-06-30 | 2022-06-30 | 生理学的に許容される酵母組成物及びそれらの使用 |
| JP2023581076A Pending JP2024526282A (ja) | 2021-06-30 | 2022-06-30 | 胃腸疾患の処置において使用する為の生理学的に許容される酵母組成物 |
| JP2023581075A Withdrawn JP2024524502A (ja) | 2021-06-30 | 2022-06-30 | 生理学的に許容される酵母組成物及びそれらの使用 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023581073A Pending JP2024524501A (ja) | 2021-06-30 | 2022-06-30 | 生理学的に許容される酵母組成物及びそれらの使用 |
| JP2023581076A Pending JP2024526282A (ja) | 2021-06-30 | 2022-06-30 | 胃腸疾患の処置において使用する為の生理学的に許容される酵母組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20240316131A1 (cg-RX-API-DMAC7.html) |
| EP (3) | EP4362710A1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2024524501A (cg-RX-API-DMAC7.html) |
| KR (3) | KR20240037257A (cg-RX-API-DMAC7.html) |
| AU (3) | AU2022302361A1 (cg-RX-API-DMAC7.html) |
| CA (3) | CA3223134A1 (cg-RX-API-DMAC7.html) |
| CO (3) | CO2024000322A2 (cg-RX-API-DMAC7.html) |
| IL (3) | IL309525A (cg-RX-API-DMAC7.html) |
| MX (3) | MX2023015507A (cg-RX-API-DMAC7.html) |
| WO (3) | WO2023275325A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3223134A1 (en) * | 2021-06-30 | 2023-01-05 | Carlos DE LECEA | Physiologically acceptable yeast compositions for use in the treatment of a gastro-intestinal disorder |
| WO2025104171A1 (en) * | 2023-11-14 | 2025-05-22 | Ab Mauri (Uk) Ltd | Physiologically acceptable microbiological compositions comprising lactic acid bacteria and kluyveromyces marxianus yeast and uses thereof |
| CN117866854B (zh) * | 2024-03-08 | 2024-06-07 | 广州同康生物科技有限公司 | 修复胃肠黏膜损伤的罗伊氏粘液乳杆菌bn01及其后生元 |
| WO2025233827A1 (en) * | 2024-05-10 | 2025-11-13 | A. Menarini International Licensing S.A. | Beneficial complementary symbiotic and mineral mix |
| EP4732843A1 (en) * | 2024-10-22 | 2026-04-29 | Lesaffre et Compagnie | Live saccharomyces cerevisiae strains for the treatment of bone-loss disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101654537B1 (ko) | 2007-12-26 | 2016-09-06 | 르샤프르 에 꽁빠니 | 인간 및/또는 동물 영양을 위한 조성물, 이의 용도 및 효모균 |
| EA202090769A1 (ru) * | 2018-05-04 | 2020-06-11 | Борис Славинович ФАРБЕР | Пищевая, косметическая и фармацевтическая композиция с иммуномодулирующим и протективным антивирусным эффектом |
| CN111944725B (zh) * | 2020-08-24 | 2021-12-07 | 汤臣倍健股份有限公司 | 一种副干酪乳杆菌207-27及其应用 |
| CA3223134A1 (en) * | 2021-06-30 | 2023-01-05 | Carlos DE LECEA | Physiologically acceptable yeast compositions for use in the treatment of a gastro-intestinal disorder |
-
2022
- 2022-06-30 CA CA3223134A patent/CA3223134A1/en active Pending
- 2022-06-30 JP JP2023581073A patent/JP2024524501A/ja active Pending
- 2022-06-30 AU AU2022302361A patent/AU2022302361A1/en active Pending
- 2022-06-30 AU AU2022303105A patent/AU2022303105A1/en active Pending
- 2022-06-30 IL IL309525A patent/IL309525A/en unknown
- 2022-06-30 MX MX2023015507A patent/MX2023015507A/es unknown
- 2022-06-30 KR KR1020247003284A patent/KR20240037257A/ko active Pending
- 2022-06-30 WO PCT/EP2022/068197 patent/WO2023275325A1/en not_active Ceased
- 2022-06-30 MX MX2023015498A patent/MX2023015498A/es unknown
- 2022-06-30 KR KR1020247003278A patent/KR20240037981A/ko active Pending
- 2022-06-30 AU AU2022303106A patent/AU2022303106A1/en active Pending
- 2022-06-30 CA CA3223303A patent/CA3223303A1/en active Pending
- 2022-06-30 JP JP2023581076A patent/JP2024526282A/ja active Pending
- 2022-06-30 KR KR1020247003283A patent/KR20240037256A/ko active Pending
- 2022-06-30 MX MX2023015516A patent/MX2023015516A/es unknown
- 2022-06-30 US US18/575,600 patent/US20240316131A1/en active Pending
- 2022-06-30 EP EP22735002.2A patent/EP4362710A1/en active Pending
- 2022-06-30 WO PCT/EP2022/068151 patent/WO2023275293A1/en not_active Ceased
- 2022-06-30 WO PCT/EP2022/068192 patent/WO2023275323A1/en not_active Ceased
- 2022-06-30 EP EP22735003.0A patent/EP4362711A1/en active Pending
- 2022-06-30 CA CA3223136A patent/CA3223136A1/en active Pending
- 2022-06-30 JP JP2023581075A patent/JP2024524502A/ja not_active Withdrawn
- 2022-06-30 EP EP22735004.8A patent/EP4362712A1/en active Pending
- 2022-06-30 US US18/575,677 patent/US20240325475A1/en active Pending
- 2022-06-30 US US18/575,656 patent/US20240293488A1/en active Pending
- 2022-06-30 IL IL309519A patent/IL309519A/en unknown
- 2022-06-30 IL IL309521A patent/IL309521A/en unknown
-
2024
- 2024-01-16 CO CONC2024/0000322A patent/CO2024000322A2/es unknown
- 2024-01-16 CO CONC2024/0000323A patent/CO2024000323A2/es unknown
- 2024-01-16 CO CONC2024/0000344A patent/CO2024000344A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024524502A5 (cg-RX-API-DMAC7.html) | ||
| JP2024524501A5 (cg-RX-API-DMAC7.html) | ||
| JP7315791B2 (ja) | Ｂｉｆｉｄｏｂａｃｔｅｒｉｕｍ ｂｒｅｖｅ ２０７－１およびその使用 | |
| JP7263622B2 (ja) | Ｌａｃｔｏｂａｃｉｌｌｕｓ ｐａｒａｃａｓｅｉ ２０７－２７およびその使用 | |
| De Vries et al. | Lactobacillus plantarum—survival, functional and potential probiotic properties in the human intestinal tract | |
| CN102791849B (zh) | 含乳酸菌制剂 | |
| IL309521A (en) | Physiologically adapted yeast preparations and their uses | |
| JP2011509651A5 (cg-RX-API-DMAC7.html) | ||
| JP4942831B2 (ja) | 抗アレルギー用組成物 | |
| RU2010131018A (ru) | Композиция для питания человека и/или животного, ее применение, дрожжи | |
| KR20100063500A (ko) | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 | |
| TW200944215A (en) | Lactobacillus isolates having anti-inflammatory activities and uses of the same | |
| JP2023502708A (ja) | ビフィドバクテリウム・ラクティスｂｌ－９９の腸管炎症の抑制における新規な用途 | |
| CN118843685A (zh) | 新的益生菌及其用途 | |
| JP2024526282A5 (cg-RX-API-DMAC7.html) | ||
| EP2925162A1 (en) | Synbiotic composition and use thereof | |
| CN118251136A (zh) | 生理学上可接受的酵母菌组合物及其用途 | |
| Mahasneh et al. | Probiotics and traditional fermented foods: The eternal connection (Mini-Review) | |
| JP7225364B1 (ja) | 乳酸菌 | |
| KR20220097324A (ko) | 케스토스를 이용한 장내 미생물의 생육 억제 용도 | |
| Thakkar et al. | Therapeutic Impacts of Probiotics--as Magic Bullet. | |
| JP4377117B2 (ja) | 炎症性疾患の改善用組成物 | |
| KR20180104503A (ko) | 케피어 유래 효모를 포함하는 프로바이오틱스 | |
| JP2023016416A (ja) | 免疫増進用組成物 | |
| KR102830181B1 (ko) | 면역밸런스 조절효과를 보유한 비피도박테리움 롱검 rapo 및 락토바실러스 플랜타럼 lrcc5264 복합체 및 이의 용도 |